Tirzepatid

A dual GIP/GLP-1 receptor agonist, known as an approved medication and listed here as a research substance for metabolic regulation.

Tirzepatide is a dual GIP/GLP-1 receptor agonist approved as a medication under the names Mounjaro and Zepbound. It is the subject of extensive clinical research on metabolic and weight regulation in type 2 diabetes and obesity. The research batches listed here are not equivalent to approved medications and are intended for laboratory use only.

Facts

Evidence

Frequently asked questions

Is tirzepatide an approved medication?
Yes, tirzepatide is approved as a prescription medication under the names Mounjaro and Zepbound. The substance described here is a research batch only, not a finished pharmaceutical product.

How does tirzepatide differ from semaglutide?
Semaglutide acts only on the GLP-1 receptor, while tirzepatide additionally acts on the GIP receptor. In a head-to-head trial, tirzepatide showed larger effects on HbA1c and body weight than semaglutide.

What is tirzepatide used for as a medication?
As an approved medication, tirzepatide is prescribed for type 2 diabetes and weight management. This page describes the substance exclusively as a research chemical for laboratory purposes.

Documented prices

List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.

VendorPackList pricePrice/mgRecordedSource
Peak Peptide5 mg39.9 EUR7.98 EUR/mg2026-09-15Product page · Ad
Europa-Peptide5 mg44.9 EUR8.98 EUR/mg2026-09-15Product page · Ad
Smart Peptides10 mg59.9 EUR5.99 EUR/mg2026-09-15Product page · Ad
Peptide Shop Deutschland10 mg84.99 EUR8.5 EUR/mgnot establishedProduct page · Ad
Licensed Peptides5 mg53.99 USD10.8 USD/mg2026-09-15Product page · Ad
American Peptides10 mg100 USD10.0 USD/mg2026-09-15Product page · Ad
Hydro Research Peptides15 mg124.99 USD8.33 USD/mg2026-09-15Product page · Ad
BioCollex20 mg80 USD4.0 USD/mg2026-09-15Product page · Ad

← Back to Peptides